Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fuller's sees profits surge after 'excellent' year

(Sharecast News) - Pubs and hotels group Fuller's has hailed an "excellent" 12 months, with adjusted profits up by a third over the period to 29 March, while good trading momentum continuing into the new financial year. Adjusted pre-tax profit totalled £27m for the year, up 32% on the £20.5m reported previously, as revenues rose 4.8% to £376m. Adjusted earnings per share rose to 34.22p from 24.48p.

Like-for-like sales were up 5.2%, with solid growth seen across all operations: food LFL sales rose 4.8%, drink LFL sales rose 5.3% and accommodation LFL sales rose 5.4%.

Meanwhile, profits were helped by the transfer of 23 smaller managed pubs to the Tenanted Inns division, along with the sale of 37 non-core tenanted pubs. The move raised £18m of capital, which went towards Fuller's acquisition of Lovely Pubs last August for £22.5m.

The board declared a final dividend of 12.35p, up 11% on last year, taking the full-year payout up to 19.76p, also up 11% on last year.

"It has been an excellent year for Fuller's," said chief executive Simon Emeny.

"We have converted this strong revenue growth into improved profitability with adjusted profit before tax rising by 32% and even more pleasing is that these results, combined with our effective allocation of capital, have delivered impressive adjusted earnings per share growth of 40%."

The new financial year has also started well, with LFL sales up 4.2% over the first 10 weeks, with the company "well-positioned to continue to deliver excellent returns to shareholders through future growth and prudent balance sheet management", it said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.